ASCP Chemistry Study Guide for MLT/MLS
Certification
D. Angiotensinogen II
1. Aldosterone is released by the adrenal
cortex upon stimulation by:
A. Renin
B. Monitoring the
B. Angiotensinogen
course of known
C. Angiotenisinogen I
cancer
D. Angiotensinogen II
2. Clinical Assays for tumor markers are most
important for:
A. screening for the presence of cancer
B. monitoring the course of known cancer
C. confirming the absence of disease
D. identifying patients at risk for cancer
3. Detection of which of the following substances is most A. alpha-
fetoprotein
useful to monitor the course of a patient with
testicular cancer?
A. alpha-fetoprotein
B. carcinoembryonic antigen
C. prolactin
D. testosterone
4. Increased concentrations of alpha-fetoprotein (AFP) in A.
hepatocellular carcino-
adults are most characteristically associated with: ma
1/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
A. hepatocellular carcinoma
B. alcoholic cirrhosis
C. chronic active hepatitis
D. multiple myeloma
5. D. Colon
2/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
Carcinoembryonic antigen (CEA) is most likely to
be produced in a maignancy involving the:
A. Brain
B. Testes
C. Bone
D. Colon
6. Which of the following is useful in the A. total prostate-specific
detection an management of carcinoma of antigen
the prostate?
A. total prostate-specific antigen
B. prostatic acid phosphatase
C. human chorionic gonadotropin
D. alpha-fetoprotein
D. tumors are useful in
7. Which of the following statements most tracking the eflcacy
correctly de- scribes the utility of clinical of treatment
laboratory assays for tu- mor markers?
A. tumor markers are useful to screen
asymptomatic patients for tumors
B. tumor markers are highly specific
C. tumor markers indicate the likelihood of an
individ- ual developing a tumor
D. tumors are useful in tracking the efficacy
of treat- ment
8. Cancer antigen 125 (CA 125) is a tumor marker associ- D. ovarian and
endometri-
ated with: A. breast
carcinoma
3/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
B. colon cancer al carcinoma
4/
34
Certification
D. Angiotensinogen II
1. Aldosterone is released by the adrenal
cortex upon stimulation by:
A. Renin
B. Monitoring the
B. Angiotensinogen
course of known
C. Angiotenisinogen I
cancer
D. Angiotensinogen II
2. Clinical Assays for tumor markers are most
important for:
A. screening for the presence of cancer
B. monitoring the course of known cancer
C. confirming the absence of disease
D. identifying patients at risk for cancer
3. Detection of which of the following substances is most A. alpha-
fetoprotein
useful to monitor the course of a patient with
testicular cancer?
A. alpha-fetoprotein
B. carcinoembryonic antigen
C. prolactin
D. testosterone
4. Increased concentrations of alpha-fetoprotein (AFP) in A.
hepatocellular carcino-
adults are most characteristically associated with: ma
1/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
A. hepatocellular carcinoma
B. alcoholic cirrhosis
C. chronic active hepatitis
D. multiple myeloma
5. D. Colon
2/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
Carcinoembryonic antigen (CEA) is most likely to
be produced in a maignancy involving the:
A. Brain
B. Testes
C. Bone
D. Colon
6. Which of the following is useful in the A. total prostate-specific
detection an management of carcinoma of antigen
the prostate?
A. total prostate-specific antigen
B. prostatic acid phosphatase
C. human chorionic gonadotropin
D. alpha-fetoprotein
D. tumors are useful in
7. Which of the following statements most tracking the eflcacy
correctly de- scribes the utility of clinical of treatment
laboratory assays for tu- mor markers?
A. tumor markers are useful to screen
asymptomatic patients for tumors
B. tumor markers are highly specific
C. tumor markers indicate the likelihood of an
individ- ual developing a tumor
D. tumors are useful in tracking the efficacy
of treat- ment
8. Cancer antigen 125 (CA 125) is a tumor marker associ- D. ovarian and
endometri-
ated with: A. breast
carcinoma
3/
34
, ASCP Chemistry Study Guide for MLT/MLS
Certification
B. colon cancer al carcinoma
4/
34
